SCHEMBL23474196

SCHEMBL23474196

C[C@H]1CCc2ccc(O)cc2CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.56
DRD3 P35462 12/20 0.56
OPRK1 P41145 1/20 0.56
DRD4 P21917 8/20 0.56
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HTR1A P08908 1/20 0.49
ADRB2 P07550 1/20 0.49
CYP2D6 P10635 1/20 0.49
CASP1 P29466 1/20 0.49
DRD1 P21728 3/20 0.48
DRD5 P21918 3/20 0.48
LMNA P02545 2/20 0.47
MAPT P10636 1/20 0.47
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
ACHE P22303 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10247150 0.88 DRD3 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL629321 0.88 OPRK1 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL18566685 0.88 OPRK1 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL24540244 0.88 OPRK1 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL10247281 0.88 DRD3 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL8408108 0.79
Ammonia Solution, Strong SCHEMBL21632258 0.77 DRD2 (0.54) DRD2DRD3OPRK1DRD4DRD1
SCHEMBL10382832 0.76 OPRK1 (0.62) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL6211308 0.76 DRD2 (0.49) DRD2DRD3OPRK1DRD4MEN1
SCHEMBL6211310 0.76 OPRK1 (0.49) DRD2DRD3OPRK1DRD4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021109713-A1 USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES GANNEX PHARMA CO., LTD. (CN) 2021-06-10 WO disclosed
WO-2021108974-A1 COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF GANNEX PHARMA CO., LTD (CN) 2021-06-10 WO disclosed
WO-2021109712-A1 COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF GANNEX PHARMA CO., LTD. (CN) 2021-06-10 WO disclosed